UNSPSC 51392005: Fenoldopam mesilate or mesylate

This classification denotes a dopamine agonist with the molecular formula C16H16ClNO3.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HA3R0MY016, chemically known as 1h-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate (salt), but more generally known as fenoldopam mesylate, which bears US NIH Compound Identifier 3341. European Medicines Agency schedules fenoldopam mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07577MIG.

UNSPSC 51392005 Fenoldopam mesilate or mesylate is a Commodity code nominally describing a specific pharmaceutical agent, but recent state and local procurement activity under this code does not reflect pharmaceutical procurement aligned with the code's name. The single recent opportunity posted under this code — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and safe drug deactivation systems, which fall outside the scope of fenoldopam mesilate procurement. This mismatch suggests either a data-classification error in the source material or incidental tagging that does not reflect the code's intended use. The code shows minimal relevant recent activity for business development purposes.

Seminole County, Florida posted the IFB on June 30, 2026, with a response deadline of July 26, 2023 (the deadline date appears to contain a data inconsistency in the source). The county seeks to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs, meet drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract structure includes an initial two-year term with an option for one-year renewal. FEMA funding may apply, introducing additional compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. Given the disconnect between the code's pharmaceutical scope and the naloxone-and-deactivation-system procurement, pursuit under this code classification should be validated against the actual commodity coding used in the source jurisdiction's RFQ documentation.